Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Sagimet Biosciences Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
|
| Security |
| Security |
| Fee |
| Amount |
| Proposed |
| Maximum |
| Fee Rate |
| Amount of |
Fees to Be Paid |
| Equity |
| Series A common stock, par value $0.0001 per share |
| 457(o) |
| — |
| — |
| $190,647,000 |
| 0.0001476 |
| $28,139.50 |
|
| Total Offering Amounts |
|
| $190,647,000 |
|
| $28,139.50 | ||||||||
|
| Total Fees Previously Paid |
|
|
|
| — | |||||||||
|
| Total Fee Offsets |
|
|
|
| — | |||||||||
|
| Net Fee Due |
|
|
|
|
|
|
| $28,139.50 |
(1) | Estimated solely for the purpose of computing the registration fee in pursuant to Rule 457(o) under the Securities Act of 1933, as amended, and includes 1,350,000 shares of Series A common stock that the underwriters have the option to purchase. |